These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22521015)

  • 21. The societal value of universal childhood vaccination.
    Chabot I; Goetghebeur MM; Grégoire JP
    Vaccine; 2004 May; 22(15-16):1992-2005. PubMed ID: 15121312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic reactions to vaccines.
    Alves RR; Gaspar A; Ferreira MB
    Eur Ann Allergy Clin Immunol; 2007 Oct; 39(8):269-77. PubMed ID: 18237005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).
    Díez-Domingo J; Ridao-López M; Gutiérrez-Gimeno MV; Puig-Barberá J; Lluch-Rodrigo JA; Pastor-Villalba E
    Vaccine; 2011 Dec; 29(52):9640-8. PubMed ID: 22027484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
    Taitel M; Cohen E; Duncan I; Pegus C
    Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
    Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
    Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects.
    Claes C; Reinert RR; von der Schulenburg JM
    Eur J Health Econ; 2009 Feb; 10(1):25-38. PubMed ID: 18379830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness of influenza vaccination The Netherlands].
    Reinders A; Postma MJ; Govaert TM; Sprenger MJ
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):93-7. PubMed ID: 9036354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the health of Oklahomans through clinical prevention, Part III: Immunizations and chemoprophylaxis.
    Crutcher JM; DeRose DJ; DePersio SR
    J Okla State Med Assoc; 2000 Dec; 93(12):557-66. PubMed ID: 11197951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodological issues and new developments in the economic evaluation of vaccines.
    Beutels P; Van Doorslaer E; Van Damme P; Hall J
    Expert Rev Vaccines; 2003 Oct; 2(5):649-60. PubMed ID: 14711326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insufficient vaccination is a threat against world health].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):831. PubMed ID: 12693127
    [No Abstract]   [Full Text] [Related]  

  • 32. [Influenza vaccination].
    Bleisch F
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1091-5. PubMed ID: 9691343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine preventable diseases and vaccination policy for indigenous populations.
    Menzies RI; Singleton RJ
    Pediatr Clin North Am; 2009 Dec; 56(6):1263-83. PubMed ID: 19962021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evidence of influenza vaccination in children.
    Savidan E; Chevat C; Marsh G
    Health Policy; 2008 May; 86(2-3):142-52. PubMed ID: 18054109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.
    Committee on Infectious Diseases
    Pediatrics; 2009 Oct; 124(4):1216-26. PubMed ID: 19736264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
    Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of influenza vaccination programs in Japan.
    Hirota Y; Kaji M
    Vaccine; 2008 Nov; 26(50):6451-4. PubMed ID: 18573292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.